ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 110 out of 761

$500K Total Retail Price of All Prescriptions

Rank: 128 out of 761

448 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

18% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,068 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
AMLODIPINE BESYLATE 531 473 1 6
LISINOPRIL 450 401 2 1
SIMVASTATIN 450 437 2 2
LEVOTHYROXINE SODIUM 373 341 4 3
FUROSEMIDE 344 321 5 7
METOPROLOL SUCCINATE 276 255 6 16
HYDROCODONE-ACETAMINOPHEN 242 208 S3 7 5
CITALOPRAM HBR 213 188 8 19
OMEPRAZOLE 196 189 9 4
WARFARIN SODIUM 161 139 10 9
ATENOLOL 152 128 11 8
TRAZODONE HCL 140 101 12 23
METFORMIN HCL ER 139 105 13 67
GLIMEPIRIDE 132 107 14 48
TAMSULOSIN HCL 129 128 15 27
ISOSORBIDE MONONITRATE ER 126 122 16 72
HYDROCHLOROTHIAZIDE 126 107 16 11
GABAPENTIN 123 102 18 15
ATORVASTATIN CALCIUM 123 120 18 12
BYSTOLIC 113 106 20 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 112 104 21 35
LOSARTAN POTASSIUM 111 108 22 13
METFORMIN HCL 106 87 23 10
FAMOTIDINE 97 83 24 60
METOPROLOL TARTRATE 97 96 24 14
TORSEMIDE 95 86 26 165
LANTUS SOLOSTAR 87 83 27 94
LOSARTAN-HYDROCHLOROTHIAZIDE 85 85 28 65
PREDNISONE 83 82 29 30
BISOPROLOL FUMARATE 82 82 30 223
BUPROPION HCL SR 80 74 31 93
CYMBALTA 79 57 32 53
CLOPIDOGREL 74 70 33 66
ALENDRONATE SODIUM 68 68 34 21
POTASSIUM CHLORIDE 67 61 35 18
CARVEDILOL 67 61 35 26
NAPROXEN 66 41 37 105
LOVASTATIN 66 58 37 17
PRAVASTATIN SODIUM 66 60 37 20
SERTRALINE HCL 62 51 40 25
NAMENDA 61 61 41 59
DOXAZOSIN MESYLATE 60 60 42 55
SPIRONOLACTONE 59 51 43 45
MIRTAZAPINE 57 57 44 50
DONEPEZIL HCL 55 55 45 33
VENLAFAXINE HCL ER 54 54 46 76
TRAMADOL HCL 54 49 46 34
LANTUS 54 54 46 41
TERAZOSIN HCL 51 51 49 86
ESCITALOPRAM OXALATE 51 48 49 102
ZOLPIDEM TARTRATE 50 47 51 22
ALLOPURINOL 50 50 51 28
FENTANYL 50 50 S2 51 57
CYCLOBENZAPRINE HCL 50 29 R 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.